"All of that is regulated by your hormones," CEO Rustamova told TechCrunch. "We know now how much they regulate in terms of your day-to-day life."
Level Zero's approach is to build a sensor that detects and measures different hormones by scanning what's known as aptamers. These are single-stranded DNA (ssDNA) molecules that specifically bind to target molecules and undergo reversible conformational changes detectable by electrochemical and optical methods."
If they succeed - and there are some positive early indicators - they will create a continuous hormone monitoring device. Such a device could do for hormone health what continuous blood glucose monitors (CGM) have done for diabetes health.
Level Zero is hoping to create this device quickly by adapting the kind of FDA-approved needles used in CGM devices to continuous hormone monitoring. That’s an easy sentence to write. It’s a much harder task to accomplish because the sensors, and even the science behind it, is all just now being developed.
Collection
[
|
...
]